A 10-year bibliometric analysis of osteosarcoma and cure from 2010 to 2019

BMC Cancer

Yan Meng¹  Zhengbo Tao¹  Kaicheng Wen¹  Siming Zhou¹  Wacili Da¹  Keda Yang¹  Lin Tao¹ 

[1] Department of Orthopedics, The First Hospital of China Medical University, 155 Nan Jing North Street, 110001, Shenyang, Liaoning, China;

关键词: Osteosarcoma;    Cure;    Bibliometric analysis;    Hotspots;    Co-word biclustering analysis;   

DOI  :  10.1186/s12885-021-07818-4

来源: Springer

【 摘 要 】

BackgroundIn recent decades, the 5-year survival rate of osteosarcoma remains poor, despite the variety of operations, and exploration of drug therapy has become the key to improvement. This study investigates the contribution of different aspects in osteosarcoma and cure, and predicts research hotspots to benefit future clinical outcomes.MethodsThe Web of Science and PubMed databases were queried to collect all relevant publications related to osteosarcoma and cure from 2009 to 2019. These data were imported into CiteSpace and the Online Analysis Platform of Literature Metrology for bibliometric analysis. Bi-clustering was performed on Bibliographic Item co-occurrence Matrix Builder (BICOMB) and gCLUTO to identify hotspots. Additionally, completed clinical trials on osteosarcoma with results past phase II were collated.ResultsA total of 2258 publications were identified in osteosarcoma and cure from 2009 to 2019. China has the largest number of publications (38.49%), followed by the United States (23.03%) with the greatest impact (centrality = 0.44). The centrality of most institutions is < 0.1, and Central South University and Texas MD Anderson Cancer Center possess the highest average citation rates of 3.25 and 2.87. BMC cancer has the highest average citation rate of 3.26 in 772 journals. Four authors (Picci P, Gorlick R, Bielack SS and Bacci G) made the best contributions. We also identified eight hotspots and collected 41 clinical trials related to drug research on osteosarcoma.ConclusionsThe urgent need exists to strengthen global academic exchanges. Overcoming multidrug resistance in osteosarcoma is the focus of past, present and future investigations. Transformation of the metastasis pattern, microenvironment genetics mechanism, alternative methods of systemic chemotherapy and exploration of traditional Chinese medicine is expected to contribute to a new upsurge of research.

【 授权许可】

CC BY